SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech - Quaterly Results

13 Aug 2024 Evaluate
The company's total revenue for the quarter ended June 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 414.82 millions.Net profit of the cmpany stood at Rs. 22.57 millions for the quarter ended June 2024 a decline of -48.91% from Rs. 44.18 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 54.35 millions from 77.91 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 414.82 405.03 2.42 414.82 405.03 2.42 1723.86 1378.84 25.02
Other Income 5.75 3.79 51.72 5.75 3.79 51.72 23.03 24.62 -6.46
PBIDT 54.35 77.91 -30.24 54.35 77.91 -30.24 282.74 266.09 6.26
Interest 6.78 9.57 -29.15 6.78 9.57 -29.15 43.77 29.23 49.74
PBDT 47.57 68.34 -30.39 47.57 68.34 -30.39 238.97 236.86 0.89
Depreciation 17.42 16.80 3.69 17.42 16.80 3.69 70.08 63.54 10.29
PBT 30.15 51.54 -41.50 30.15 51.54 -41.50 168.89 173.32 -2.56
TAX 7.58 7.36 2.99 7.58 7.36 2.99 35.90 23.31 54.01
Deferred Tax -0.78 -5.10 -84.71 -0.78 -5.10 -84.71 -6.27 -13.69 -54.20
PAT 22.57 44.18 -48.91 22.57 44.18 -48.91 132.99 150.01 -11.35
Equity 127.15 126.51 0.51 127.15 126.51 0.51 127.15 126.51 0.51
PBIDTM(%) 13.10 19.24 -31.89 13.10 19.24 -31.89 16.40 19.30 -15.01

Medicamen Biotech Share Price

258.50 10.00 (4.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×